These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3006281)

  • 1. Polymorphisms within the HLA-DR4 haplotypes. Various DQ subtypes detected with monoclonal antibodies.
    Bontrop RE; Schreuder GM; Mikulski EM; van Miltenburg RT; Giphart MJ
    Tissue Antigens; 1986 Jan; 27(1):22-31. PubMed ID: 3006281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structural analysis of DR and DQ molecules among three HLA-D clusters associated with HLA-DR4].
    Ikeda H
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):898-907. PubMed ID: 2417927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
    Karr RW
    J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A monoclonal antibody recognizes a novel HLA-DQ specificity, DQWa].
    Ishikawa N
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):635-42. PubMed ID: 2416664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular variation of human major histocompatibility complex DQw3 beta-chains.
    So AK; Lindsay J; Bodmer J; Trowsdale J
    J Immunol; 1987 Nov; 139(10):3506-11. PubMed ID: 2890689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.
    Tilanus MG; Morolli B; van Eggermond MC; Schreuder GM; de Vries RR; Giphart MJ
    Immunogenetics; 1986; 23(5):333-40. PubMed ID: 3011659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymorphism of the class II genes in DR4 cells.
    So A; Bodmer J
    Dis Markers; 1986 Jun; 4(1-2):165-72. PubMed ID: 2898313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry of HLA-DRw6: evidence for seven distinct haplotypes.
    Haziot A; Lepage V; Freidel AC; Betuel H; Degos L; Charron DJ
    J Immunol; 1986 May; 136(10):3767-72. PubMed ID: 3486222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of three HLA class II molecules on DR4 and DRw9 haplotypes: serologic and structural relationships at the polypeptides level.
    Maeda H; Hirata R; Thompson A; Mukai R
    Hum Immunol; 1986 Jan; 15(1):1-15. PubMed ID: 2419281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism.
    Schreuder GM; Tilanus MG; Bontrop RE; Bruining GJ; Giphart MJ; van Rood JJ; de Vries RR
    J Exp Med; 1986 Sep; 164(3):938-43. PubMed ID: 3462303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular complexity of HLA-DQw3: the TA10 determinant is located on a subset of DQw3 beta chains.
    Radka SF; Scott RG; Stewart SJ
    Hum Immunol; 1987 Apr; 18(4):287-300. PubMed ID: 2437090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies.
    Schreuder GM; Maeda H; Koning F; D'Amaro J
    Hum Immunol; 1986 Jun; 16(2):127-36. PubMed ID: 2424871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci.
    Wu S; Saunders TL; Bach FH
    Nature; 1986 Dec 18-31; 324(6098):676-9. PubMed ID: 3099214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.